Urokinase activates the Jak/Stat signal transduction pathway in human vascular endothelial cells

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 2, 1999, Pages 290-297

  Dumler, Inna ^a,c   Kopmann, Angela ^a   Weis, Angelika ^a   Mayboroda, Oleg A ^b   Wagner, Kai ^a   Gulba, Dietrich C ^a   Haller, Hermann ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

^c FRANZ VOLHARD CLINIC   (Germany)

Author keywords

Endothelial cells; Jak Stat pathway; Signal transduction; Urokinase receptor

Indexed keywords

UROKINASE; UROKINASE RECEPTOR;

ANGIOGENESIS; ARTICLE; BLOOD VESSEL INJURY; CELL MIGRATION; CELL PROLIFERATION; ELECTROPHORETIC MOBILITY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

EID: 0033045293     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.2.290     Document Type: Article

References (43)

1. Beck L Jr, D'Amore PA. Vascular development: cellular and molecular regulation. FASEB J. 1997;11:365-373.
2. Mantovani A, Bussolino F, Introna M. Cytokine regulation of endothelial cell function: from molecular level to the bedside. Immunol Today. 1997;18:231-240.
3. Gimbrone MA Jr. Vascular endothelium: an integrator of pathophysiologic stimuli in atherosclerosis. Am J Cardiol. 1995;75:67B-70B.
4. Casscells W. Migration of smooth muscle and endothelial cells: critical events in restenosis. Circulation. 1992;86:723-729.
5. Ruoslahti E, Engvall E. Integrins and vascular extracellular matrix assembly. J Clin Invest. 1997;99:1149-1152.
6. Shattil SJ, Ginsberg MH. Integrins signaling in vascular biology. J Clin Invest. 1997;100:1-5.
7. Moscatelli D, Rifkin DB. Membrane and matrix localization of proteases: a common theme in tumor invasion and angiogenesis. Biochim Biophys Acta. 1988;948:67-85.
8. Pepper MS, Montesano R. Proteolytic balance and capillary morphogenesis. Cell Differ Dev. 1991;32:319-328.
9. Saskela O, Rifkin DB. Cell associated plasminogen activation: regulation and physiological functions. Annu Rev Cell Biol. 1988;4:93-126.
10. Estriecher A, Mühlhauser J, Carpentier J.-L, Orci L, Vassalli J-D. The receptor for urokinase type plasminogen activator polarizes expression of the protease to the leading edge of migrating monocytes and promotes degradation of enzyme inhibitor complexes. J Cell Biol. 1990;111: 783-792.
11. Pepper MS, Sappino A-P, Stöcklin R, Montesano R, Orci L, Vassalli J-D. Upregulation of urokinase receptor on migrating endothelial cells. J Cell Biol. 1993;122:673-684.
12. Okada SS, Tomaszewski JE, Barnathan ES. Migrating vascular smooth muscle cells polarize cell surface urokinase receptors after injury in vitro. Exp Cell Res. 1995;217:180-187.
13. Lu H, Mabilat C, Yeh P, Guitton J-D, Li H, Pouchelet M, Shoevaert D, Legrand Y, Soria J, Soria C. Blockage of urokinase receptor reduces in vitro the motility and the deformability of endothelial cells. FEBS Lett. 1996;380:21-24.
14. Reidy MA, Irvin C, Lindner V. Migration of arterial wall cells: expression of plasminogen activators and inhibitors in injured rat arteries. Circ Res. 1996;78:405-414.
15. Del Rosso M, Anichini E, Pedersen N, Blasi F, Fibbi G, Pucci M, Ruggiero M. Urokinase-urokinase receptor interaction: non-mitogenic signal transduction in human epidermal cells. Biochem Biophys Res Commun. 1993;190:347-352.
16. Busso N, Masur SK, Lazeda D, Waxman S, Ossowski L. Induction of cell migration by pro-urokinase binding to its receptor: possible mechanism for signal transduction in human epithelial cells. J Cell Biol. 1994;128: 259-270.
17. Dumler I, Petri T, Schleuning W-D. Induction of c-fos gene by urokinase plasminogen activator in human ovarian cancer cells. FEBS Lett. 1994; 343:103-106.
18. Bohuslav J, Horejsi V, Hansmann C, Stöckl J, Weidle, UH, Majdic O, Bartke I, Knapp W, Stockinger H. Urokinase plasminogen activator receptor, β2-integrins, and Src-kinases within a single receptor complex of human monocytes. J Exp Med. 1995;181:1381-1390.
19. Resnati M, Guttinger M, Valcamonica S, Sidenius N, Blasi F, Fazioli F. Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effect. EMBO J. 1996;15:1572-1582.
20. Wei Y, Lukashev, M, Simon DI, Bodary SC, Rosenberg S, Doyle MV, Chapman HA. Regulation of integrin function by the urokinase receptor. Science. 1996;273:1551-1555.
21. Kanse SM, Kost C, Wilhelm OG, Andreasen PA, Preissner KT. The urokinase receptor is a major vitronectin-binding protein on endothelial cells. Exp Cell Res. 1996;224:344-353.
22. Waltz DA, Natkin LR, Fujita RM, Wei Y, Chapman HA. Plasmin and plasminogen activator inhibitor type 1 promote cellular motility by regulating the interaction between the urokinase receptor and vitronectin. J Clin Invest. 1997;100:58-67.
23. Yebra M, Parry CN, Strömblad S, Mackman N, Rosenberg S, Mueller BM, Cheresh DA. Requirement of receptor-bound urokinase-type plasminogen activator for integrin avb5-directed cell migration. J Biol Chem. 1996;271:29393-29399.
24. Dumler I, Hucho F, Gulba D. Signal transduction via urokinase receptor: is a transmembrane adapter molecule really necessary? Fibrinolysis Proteolysis. 1997;11(suppl 2):165-169.
25. Briscoe J, Guschin D, Müller M. Just another signalling pathway. Curr Biol. 1994;4:1033-1035.
26. Ziemiecki A, Harpur AG, Wilks AF. JAK protein tyrosine kinases: their role in cytokine signalling. Trends Cell Biol. 1994;4:207-212.
27. Briscoe J, Kohlhuber F, Müller M. JAKs and STATs branch out. Trends Cell Biol. 1996;6:336-340.
28. Horvath CM, Darnell JE Jr. The state of the STATs: recent developments in the study of signal transduction to the nucleus. Curr Opin Cell Biol. 1997;9:233-239.
29. Yamamoto H, Crow M, Cheung L, Lakatta E, Kinsella J. PDGF receptor-to-nucleus signaling of p91 (STAT1a) transcription factor in rat smooth muscle cells. Exp Cell Res. 1996;222:125-130.
30. Decker T, Kovarik P, Meinke A. GAS elements: a few nucleotides with a major impact on cytokine-induced gene expression. J Interferon Cytokine Res. 1997;17:121-134.
31. Koshelnick Y, Ehart M, Hufnagl P, Heinrich PC, Binder BR. Urokinase receptor is associated with the components of the JAK1/STAT1 signaling pathway and leads to activation of this pathway upon receptor clustering in the human kidney epithelial tumor cell line TCL-598. J Biol Chem. 1997;272:28563-28567.
32. Dumler I, Weis A, Mayboroda OA, Maasch C, Jerke U, Haller H, Gulba DC. The Jak/Stat pathway and urokinase receptor signaling in human aortic vascular smooth muscle cells. J Biol Chem. 1998;273:315-321.
33. Zong C, Yan R, August A, Darnell JE, Hanafusa H. Unique signal transduction of Eyk: constitutive stimulation of the JAK-STAT pathway by an oncogenic receptor-type tyrosine kinase. EMBO J. 1996;15:4515-4525.
34. Kodama H, Fukuda K, Pan J, Makino S, Baba A, Hori S, Ogawa S. Leukemia inhibitory factor, a potent cardiac hypertrophic cytokine, activates the JAK/STAT pathway in rat cardiomyocytes. Circ Res. 1997;81:656-663.
35. Leaman DW, Pisharody S, Flickinger TW, Commane MA, Schlessinger J, Kerr IM, Levy DE, Stark GR. Roles of JAKs in activation of STATs and stimulation of c-fos gene expression by epidermal growth factor. Mol Cell Biol. 1996;16:369-375.
36. Ihle JN. STATs: signal transducers and activators of transcription. Cell. 1996;84:331-334.
37. Karras JG, Huo L, Wang Z, Frank DA, Zimmet JM, Rothstein TL. Delayed tyrosine phosphorylation and nuclear expression of Stat1 following antigen receptor stimulation of B lymphocytes. J Immunol. 1996; 157:2299-2309.
38. WAF/CIPI mediated by Stat1. Science. 1996;272:719-722.
39. Su WCS, Kitawaga M, Xue N, Xie B, Garofalo S, Cho J, Deng C, Horton WA, Fu XY. Activation of Stat1 by mutant fibroblast growth-factor receptor in thanatophoric dysplasia type II dwarfism. Nature. 1997;386: 288-292.
40. Marra F, Choudhury GG, Abboud HE. Interferon-γ-mediated activation of Stat1a regulates growth factor-induced mitogenesis. J Clin Invest. 1996;98:1218-1230.
41. Singh K, Balligand JL, Fischer T, Smith TW, Kelly RA. Regulation of cytokine-inducible nitric oxide synthase in cardiac myocytes and microvascular endothelial cells. Role of extracellular signal-regulated kinases 1 and 2 (ERK1/ERK2) and Stat1a. J Biol Chem. 1996;271: 1111-1117.
42. Dostal DE, Hunt RA, Kule CE, Bhat GJ, Karoor V, McWhinney CD, Baker KM. Molecular mechanisms of angiotensin II in modulating cardiac function: intracardiac effects and signal transduction pathways. J Mol Cell Cardiol. 1997;29:2893-2902.
43. Marrero MB, Schieffer B, Li B, Sun J, Harp JB, Ling BN. Role of Janus kinase/signal transducer and activator of transcription and mitogen-activated protein kinase cascades in angiotensin II- and platelet-derived growth factor-induced vascular smooth muscle cell proliferation. J Biol Chem. 1997;272:24684-24690.